Clinical Trial Update: ARISE: After 8 Hours Reperfusion in Ischemic Stroke Embolization [NA]

View source ↗

Summary

The ARISE trial evaluating after 8 hours reperfusion in ischemic stroke has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Abington Memorial Hospital | Conditions: Ischemic Stroke | NA | Status: SUSPENDED